2.50
Hdl Handle:
http://hdl.handle.net/2336/238451
Title:
A long-term follow-up of allergic diseases in Iceland.
Authors:
Finnbogadóttir, Anna Freyja; Árdal, Björn; Eiríksson, Herbert; Hrafnkelsson, Birgir; Valdimarsson, Helgi; Lúðvíksson, Björn Rúnar; Haraldsson, Ásgeir
Citation:
Pediatr. Allergy Immunol. 2012, 23(2):181-5
Issue Date:
Mar-2012
Abstract:
Allergic disorders are an increasing health problem in many countries, in particular among children. We have evaluated the prevalence and manifestations of allergy in a cohort of young Icelanders for more than two decades. Variations in the epidemiology and clinical expression of allergy in different communities may help to identify etiological factors contributing to these disorders. A cohort of 179 children has been monitored for allergic manifestations for two decades, at the ages of two, four, eight, and 15 years, and most recently at the age of 21 years involving 120 of the participants. Cumulative prevalences of 40%, 45%, and 29% have been observed, respectively, for rhinoconjunctivitis, eczema, and asthma during the study period. None had developed rhinoconjunctivitis at the age of about 2 years, but the point prevalence gradually increased to 33% at the age of 21 years. Conversely, the prevalence of eczema was 31% at the age of 2 years, but gradually declined to 8% at the age of 21 years. The prevalence of asthma peaked at 28% at the age of 4 years, but declined thereafter and has remained stable at about 13% from the age of eight to 21 years. The prevalence of allergic diseases is high in Iceland among children and young individuals. Asthma and atopic eczema are very common in childhood, but decreases with age while the prevalence of rhinoconjunctivitis increases markedly. The very high and increasing prevalence of rhinoconjunctivitis among 15- to 21-year-old individuals is noteworthy.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field.
Additional Links:
http://dx.doi.org/10.1111/j.1399-3038.2011.01234.x
Rights:
Archived with thanks to Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Full metadata record

DC FieldValue Language
dc.contributor.authorFinnbogadóttir, Anna Freyjaen_GB
dc.contributor.authorÁrdal, Björnen_GB
dc.contributor.authorEiríksson, Herberten_GB
dc.contributor.authorHrafnkelsson, Birgiren_GB
dc.contributor.authorValdimarsson, Helgien_GB
dc.contributor.authorLúðvíksson, Björn Rúnaren_GB
dc.contributor.authorHaraldsson, Ásgeiren_GB
dc.date.accessioned2012-08-14T13:13:25Z-
dc.date.available2012-08-14T13:13:25Z-
dc.date.issued2012-03-
dc.date.submitted2012-08-14-
dc.identifier.citationPediatr. Allergy Immunol. 2012, 23(2):181-5en_GB
dc.identifier.issn1399-3038-
dc.identifier.pmid22300372-
dc.identifier.doi10.1111/j.1399-3038.2011.01234.x-
dc.identifier.urihttp://hdl.handle.net/2336/238451-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.en_GB
dc.description.abstractAllergic disorders are an increasing health problem in many countries, in particular among children. We have evaluated the prevalence and manifestations of allergy in a cohort of young Icelanders for more than two decades. Variations in the epidemiology and clinical expression of allergy in different communities may help to identify etiological factors contributing to these disorders. A cohort of 179 children has been monitored for allergic manifestations for two decades, at the ages of two, four, eight, and 15 years, and most recently at the age of 21 years involving 120 of the participants. Cumulative prevalences of 40%, 45%, and 29% have been observed, respectively, for rhinoconjunctivitis, eczema, and asthma during the study period. None had developed rhinoconjunctivitis at the age of about 2 years, but the point prevalence gradually increased to 33% at the age of 21 years. Conversely, the prevalence of eczema was 31% at the age of 2 years, but gradually declined to 8% at the age of 21 years. The prevalence of asthma peaked at 28% at the age of 4 years, but declined thereafter and has remained stable at about 13% from the age of eight to 21 years. The prevalence of allergic diseases is high in Iceland among children and young individuals. Asthma and atopic eczema are very common in childhood, but decreases with age while the prevalence of rhinoconjunctivitis increases markedly. The very high and increasing prevalence of rhinoconjunctivitis among 15- to 21-year-old individuals is noteworthy.en_GB
dc.language.isoenen
dc.publisherWileyen_GB
dc.relation.urlhttp://dx.doi.org/10.1111/j.1399-3038.2011.01234.xen_GB
dc.rightsArchived with thanks to Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunologyen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshChilden_GB
dc.subject.meshChild, Preschoolen_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshFollow-Up Studiesen_GB
dc.subject.meshHumansen_GB
dc.subject.meshHypersensitivityen_GB
dc.subject.meshIcelanden_GB
dc.subject.meshInfanten_GB
dc.subject.meshMaleen_GB
dc.subject.meshPrevalenceen_GB
dc.subject.meshYoung Adulten_GB
dc.titleA long-term follow-up of allergic diseases in Iceland.en
dc.typeArticleen
dc.contributor.departmentThe Children's Hospital Iceland, Landspítali - University Hospital, Iceland.en_GB
dc.identifier.journalPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunologyen_GB
dc.rights.accessLandspitali Access - LSH-aðganguren
dc.type.categoryBarnalæknisfræði, Ónæmisfræðien_GB
All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.